RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $125
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $135 to $125.
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $135 to $125.